Literature DB >> 24324078

Evaluation of stem cell marker gene expression in canine prostate carcinoma- and prostate cyst-derived cell lines.

Mohammed Moulay1, Wen Liu, Saskia Willenbrock, Katharina Anna Sterenczak, Regina Carlson, Anaclet Ngezahayo, Hugo Murua Escobar, Ingo Nolte.   

Abstract

BACKGROUND/AIM: In human prostate cancer cells with a stem cell-like character (cancer stem cells, CSC) are considered to play a major role in disease development, progression and relapse. Aim of the study was to evaluate if similar cells are present and active in canine prostate cancer providing a naturally-occurring mammalian model for the development of therapeutic approaches targeting CSC.
MATERIALS AND METHODS: Stem cell marker expression of CD133, CD44, C-KIT, CD34, ITGA6, OCT4, DDX5 and MELK in canine prostate carcinomas and prostate cyst cell lines were screened by Polymerase Chain Reaction (PCR), quantitative Polymerase Chain Reaction (qPCR) and partially analysed by flow cytometry.
RESULTS: Marker analyses by PCR and qPCR, revealed a complex expression pattern for the analysed marker genes, providing a characteristic marker pattern for the studied cell lines. Thereby CD44, CD133, ITGA6 and DDX5 showed the most prominent expression in the analysed cell lines.
CONCLUSION: The results revealed a characteristic stem cell marker expression in the analysed cell lines, indicating the presence of CSC in canine prostate cancer.

Entities:  

Keywords:  CT1258; CT1258-EGFP; CT1258-EGFP-HMGA2 cell lines; Prostate cancer; cancer stem cells; canine; stem cell marker

Mesh:

Substances:

Year:  2013        PMID: 24324078

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

Review 1.  Comparative Pathobiology of Canine and Human Prostate Cancer: State of the Art and Future Directions.

Authors:  Eduardo de Paula Nascente; Renée Laufer Amorim; Carlos Eduardo Fonseca-Alves; Veridiana Maria Brianezi Dignani de Moura
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

2.  Antigen profiling analysis of vaccinia virus injected canine tumors: oncolytic virus efficiency predicted by boolean models.

Authors:  Alexander Cecil; Ivaylo Gentschev; Marion Adelfinger; Ingo Nolte; Thomas Dandekar; Aladar A Szalay
Journal:  Bioengineered       Date:  2014 Sep-Oct       Impact factor: 3.269

3.  Monoclonal Antibodies 13A4 and AC133 Do Not Recognize the Canine Ortholog of Mouse and Human Stem Cell Antigen Prominin-1 (CD133).

Authors:  Kristina Thamm; Sylvi Graupner; Carsten Werner; Wieland B Huttner; Denis Corbeil
Journal:  PLoS One       Date:  2016-10-04       Impact factor: 3.240

Review 4.  Cyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during Therapy.

Authors:  Lisa Y Pang; Emma A Hurst; David J Argyle
Journal:  Stem Cells Int       Date:  2016-11-01       Impact factor: 5.443

5.  Investigation of c-KIT and Ki67 expression in normal, preneoplastic and neoplastic canine prostate.

Authors:  Carlos Eduardo Fonseca-Alves; Priscilla Emiko Kobayashi; Chiara Palmieri; Renée Laufer-Amorim
Journal:  BMC Vet Res       Date:  2017-12-06       Impact factor: 2.741

6.  Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis.

Authors:  Shahid Hussain; Sonal Saxena; Sameer Shrivastava; Ashok Kumar Mohanty; Sudarshan Kumar; Rajkumar James Singh; Abhinav Kumar; Sajad Ahmad Wani; Ravi Kumar Gandham; Naveen Kumar; Anil Kumar Sharma; Ashok Kumar Tiwari; Raj Kumar Singh
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

7.  Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis.

Authors:  Eva-Maria Packeiser; Marion Hewicker-Trautwein; Heike Thiemeyer; Annika Mohr; Johannes Junginger; Jan Torben Schille; Hugo Murua Escobar; Ingo Nolte
Journal:  PLoS One       Date:  2020-03-13       Impact factor: 3.240

8.  Establishment and characterization of stable red, far-red (fR) and near infra-red (NIR) transfected canine prostate cancer cell lines.

Authors:  Wen Liu; Sina Sender; Weibo Kong; Julia Beck; Anett Sekora; Kirsten Bornemann-Kolatzki; Ekkehart Schuetz; Christian Junghanss; Bertram Brenig; Ingo Nolte; Hugo Murua Escobar
Journal:  Cancer Cell Int       Date:  2020-04-29       Impact factor: 5.722

9.  An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes.

Authors:  Heike Thiemeyer; Leila Taher; Jan Torben Schille; Eva-Maria Packeiser; Lisa K Harder; Marion Hewicker-Trautwein; Bertram Brenig; Ekkehard Schütz; Julia Beck; Ingo Nolte; Hugo Murua Escobar
Journal:  Int J Mol Sci       Date:  2021-10-25       Impact factor: 5.923

10.  Immunohistochemical panel to characterize canine prostate carcinomas according to aberrant p63 expression.

Authors:  Carlos Eduardo Fonseca-Alves; Priscila Emiko Kobayashi; Luis Gabriel Rivera Calderón; Sérgio Luis Felisbino; Jaqueline de Carvalho Rinaldi; Sandra Aparecida Drigo; Silvia Regina Rogatto; Renée Laufer-Amorim
Journal:  PLoS One       Date:  2018-06-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.